Viking Therapeutics, Inc. (VKTX)
28.44
+2.15
(+8.18%)
USD |
NASDAQ |
Feb 06, 16:00
28.47
+0.03
(+0.11%)
After-Hours: 20:00
Viking Therapeutics SG&A Expense (TTM) : 52.36M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Eli Lilly & Co. | 11.09B |
| Pfizer Inc. | 13.79B |
| Amgen, Inc. | 7.05B |
| Biogen, Inc. | 2.434B |
| Regeneron Pharmaceuticals, Inc. | 2.70B |